HHS Clinical Trial Guidance Sparks More Questions From Researchers
This article was originally published in The Gray Sheet
Executive Summary
Draft guidance from the Department of Health and Human Services' Office of Human Research Protections leaves lingering questions about how to proceed when subjects withdraw from a clinical trial, stakeholders say